1. Home
  2. PSN vs HAE Comparison

PSN vs HAE Comparison

Compare PSN & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PSN

Parsons Corporation

N/A

Current Price

$50.48

Market Cap

4.8B

Sector

Technology

ML Signal

N/A

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

N/A

Current Price

$119.30

Market Cap

5.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PSN
HAE
Founded
1944
1971
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
5.4B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
PSN
HAE
Price
$50.48
$119.30
Analyst Decision
Buy
Buy
Analyst Count
14
11
Target Price
$59.91
★ $124.50
AVG Volume (30 Days)
★ 1.1M
669.3K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 3.77
N/A
EPS
★ 0.85
0.72
Revenue
★ $6,364,245,000.00
$910,373,000.00
Revenue This Year
N/A
$6.21
Revenue Next Year
$5.15
$5.54
P/E Ratio
★ $58.09
$166.49
Revenue Growth
N/A
★ N/A
52 Week Low
$36.26
$49.24
52 Week High
$88.00
$123.77

Technical Indicators

Market Signals
Indicator
PSN
HAE
Relative Strength Index (RSI) 68.49 62.21
Support Level $48.81 $115.49
Resistance Level $52.95 $123.77
Average True Range (ATR) 1.84 3.00
MACD 0.75 -0.39
Stochastic Oscillator 87.85 46.12

Price Performance

Historical Comparison
PSN
HAE

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe. The company derives maximum revenue from Federal Solutions segment. Geographically, the company derives revenue from North America; Middle East; and Rest of the World, of which North America derives maximum revenue.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.

Share on Social Networks: